首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1542892

全球後生元食品補充品市場 - 2024-2031

Global Postbiotics Food Supplements Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 219 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球後生元食品補充劑市場達到1,080萬美元，預計2031年將達到2,730萬美元，2024-2031年預測期間複合年成長率為10.5%。

由於後生元具有經過科學驗證的健康益處、其高穩定性以及在各種產品形式中的多功能性，後生元食品補充劑市場正在獲得巨大的吸引力。後生元是益生菌微生物的非活細菌產物或代謝副產物，旨在解決廣泛的健康問題，包括腸道健康、免疫和炎症，從而推動消費者興趣和市場成長。

最近的研究表明，後生元可以比益生菌提供更直接的免疫調節作用。特定的後生元菌株已證明巨噬細胞中 IL-12 的產量有更高的增加，這對於防禦傳染病至關重要。這會導致免疫反應發生有益的變化，增強 IL-10 和 IL-12 的增殖，以及脾臟細胞和樹突狀細胞中 IFN-Y 的產生。

後生元的直接免疫調節作用提供了卓越的健康益處，並減輕了與益生菌相關的潛在負面影響。這使得後生元成為免疫受損族群（例如老年人或移植患者）更安全的替代品。

此外，後生元為產品創新提供了重要機會，特別是在益生菌效果較差的環境中。後生元的一個關鍵優勢是其穩定性，這使得它們對儲存條件不太敏感，並且適合各種遞送形式，包括片劑和膠囊。這種多功能性提高了消費者的便利性並擴大了市場潛力。

市場動態

人們對後生元改善人類健康的認知不斷提高

人們對後生元在健康和保健方面的認知和採用不斷提高，正在推動功能性食品和膳食補充劑行業的顯著成長。後生元由益生菌產生的代謝物和成分組成，透過各種機制增強人類健康，無需消耗活微生物，從而提供獨特的價值主張。消費者對促進健康的產品的需求不斷成長、對腸道健康的更加關注以及對傳統益生菌的經過科學驗證的非生命替代品的日益青睞，推動了這一趨勢。

根據 2023 年 1 月發表在學術社區百科全書 (MDPI) 上的一篇文章，後生元（微生物發酵過程中產生的生物活性化合物）已成為增強健康的一個有前景的前沿領域。這些化合物，包括乳酸、細菌素和胞外多醣 (EPS)，表現出顯著的抗菌特性。例如，乳酸和細菌素可直接抑制革蘭氏陰性病原體，突顯它們在控制病原體感染和支持腸道健康方面的作用。值得注意的是，源自乳酸桿菌和雙歧桿菌菌株的後生元已顯示出對抗腸道侵襲性大腸桿菌和其他有害微生物的功效，這對於維持平衡的微生物群和預防胃腸道疾病至關重要。

與活益生菌相比，後生元的市場潛力因其穩定性和安全性而得到增強，活益生菌經常面臨與保存期限和監管障礙相關的挑戰。隨著消費者和醫療保健從業者越來越了解後生元的優勢，包括其支持腸道健康和增強免疫功能的能力，需求預計會增加。投資後生元的公司將從越來越多具有健康意識的消費者尋求科學支持、有效和安全的膳食補充劑中受益。

越來越多的科學證據支持後生元的益處

科學研究擴大驗證後生元的健康益處，增強了它們在食品補充劑市場的吸引力。後生元是益生菌在發酵過程中產生的生物活性化合物，因其在支持腸道健康、免疫功能和整體健康方面的穩定性、安全性和有效性而受到關注。新興研究強調了它們在調節腸道微生物組、減少發炎和改善代謝健康方面的作用，進一步鞏固了它們的價值主張。越來越多的證據支持將後生元納入膳食補充劑，將後生元定位為傳統益生菌的科學基礎的穩定替代品，並推動該領域的市場成長。

根據國家醫學圖書館的數據，到 2022 年，壞死性小腸結腸炎 (NEC) 將成為一種嚴重影響嬰兒發病率和死亡率的疾病。這強調了對有效和安全的預防性治療的迫切需求。最近的治療研究已確定益生菌是 NEC 的主要潛在干預措施，特別是對於早產兒。然而，與安全性和劑量相關的擔憂限制了益生菌在這些弱勢群體的臨床環境中的實際應用。

儘管仍在研究中，後生元為活益生菌提供了一種有前途的替代或補充療法。這些源自於細菌結構，即使在微生物被熱誘導破壞後仍保留生物活性。最近對未成熟腸道的小鼠模型進行的一項研究表明，熱去活化的鼠李糖乳桿菌 GG (LGG) 在增強腸道屏障功能方面表現出與活益生菌相當的治療效果。

監管挑戰和合規問題

儘管人們越來越意識到後生元食品補充劑的潛在健康益處，但監管挑戰和合規問題對後生元食品補充劑市場構成了重大限制。

包括後生元在內的膳食補充劑的監管環境在不同地區和國家之間存在很大差異，這給製造商在產品註冊、標籤要求和健康聲明證實方面帶來了複雜性。

包括歐洲食品安全局（EFSA）和歐洲藥典在內的許多司法管轄區已經制定了益生菌和益生元的標準，但尚未制定針對後生元的具體法規。同樣，在美國，食品和藥物管理局 (FDA) 沒有為後生元提供具體指南，其監管狀態需要根據適用於類似產品的現有類別來確定。這種監管上的不確定性可能會導致後生元在不同市場的行銷和銷售方式不一致。

細分市場分析

全球後生元食品補充劑市場根據類型、形式、應用、配銷通路和地區進行細分。

食品和飲料應用中後生元的使用需求激增

近年來，後生元已成為食品和飲料領域引人注目的成分，為產品開發的創新和差異化提供了巨大的潛力。後生元包括細菌裂解物、酶、胜肽和代謝物，由於其在一系列溫度和 pH 水平下的穩定性而受到關注。這種穩定性使製造商能夠將後生元融入各種食品和飲料產品中，而不會影響其功能，從而呈現出顯著的技術和財務優勢。

後生元在食品和飲料產品的應用多種多樣，涵蓋乳製品和非乳製品領域。例如，源自發酵過程的後生元常見於克菲爾、康普茶、優格和醃製蔬菜等產品。後生元的自然融入增強了這些產品的功能特性，滿足了消費者對功能性和健康促進食品日益成長的需求。

後生元的加入也可以策略性地用於增強食品的感官和理化特性。例如，乳酸菌（LAB）產生的胞外多醣（EPS）可以改善乳製品的質地和口感，提供市場競爭優勢。此外，後生元可以促進食物富含必需維生素和生物活性化合物。例如，發酵過程可以提高穀物中 B 群維生素的含量，補償碾磨和加工過程中的營養損失。

市場地域佔有率

亞太地區對後生元食品補充劑的需求

中國、印度和日本等亞太國家的出生率不斷上升，人們越來越重視孕產婦和兒童健康。這種人口趨勢是對營養補充劑（包括後生元）需求的重要推動力，人們認知到後生元具有支持產後孕產婦健康和促進嬰兒發育的潛力。

在文化上，中國和印度等國家非常重視孕產婦福祉和新生兒的健康。後生元因其在促進腸道健康、增強免疫功能以及與優先考慮自然療法和預防性健康措施的傳統醫療實踐相一致方面的好處而受到越來越多的追捧。

儘管與益生菌和益生元相比，後生元是一個較新的領域，但它正在成為一個重要的關注領域。益生菌產生的這些代謝物因其潛在的健康益處而獲得認可，包括抗發炎和免疫調節作用。後生元的穩定性和功效正在受到嚴格審查，正在進行的研究旨在驗證其健康聲明並確保監管合規性。

COVID-19 影響分析

COVID-19 大流行對後生元食品補充劑市場產生了重大影響，既有正面的影響，也有負面的影響。從積極的一面來看，大流行期間健康意識的提高導致消費者對包括後生元在內的健康和保健產品的興趣增加。

許多消費者轉向膳食補充劑來增強免疫系統、支持整體健康和控制壓力，導致後生元產品的需求激增。這種趨勢在尋求增強產後健康和福祉的新媽媽中尤其明顯，推動了後生元食品補充劑市場的成長。

不利的一面是，疫情對全球供應鏈造成了嚴重破壞，影響了後生元補充劑所需原料的供應和成本。封鎖、旅行限制和勞動力短缺阻礙了製造和分銷流程，導致延誤和成本增加。此外，疫情引發的經濟低迷影響了消費者的購買力，可能會限制市場成長，因為一些消費者可能會削減非必要支出。

俄烏戰爭影響分析

俄羅斯-烏克蘭戰爭對全球供應鏈產生了重大影響，影響了後生元食品補充劑市場。兩國都是膳食補充劑中使用的各種原料和成分（包括後生元）的主要生產商和供應商。衝突導致這些關鍵零件的生產和出口中斷，導致全球製造商供應短缺並增加生產成本。

該地區的不穩定也導致能源價格波動，進一步推高製造和分銷成本。因此，後生元食品補充劑市場的公司在維持穩定的供應和管理增加的成本方面面臨挑戰，這可能會影響產品定價和消費者的可用性。

此外，地緣政治緊張局勢造成不確定性並影響消費者信心，從而影響了市場動態。對俄羅斯實施的經濟制裁和貿易限制使國際貿易和商業運作複雜化，導致市場活動延誤和不確定性。這對歐洲市場的影響尤其嚴重，因為歐洲市場對東歐原料的依賴程度很高。

按類型

短鏈脂肪酸

脂多醣

胞外多醣

酵素

細胞壁碎片

其他

按形式

膠囊和片劑

液體

粉末

其他

按申請

消化系統健康

腸道微生物群/微生物組平衡

消化

便秘

腹脹

其他

免疫支持

皮膚健康

體重管理

運動營養

心理健康

睡覺

認知

情緒

沮喪

一般健康

其他

按配銷通路

超市/大賣場

藥局和藥局

便利商店

網路零售商

其他分銷管道

按地區

北美洲

我們

加拿大

墨西哥

歐洲

德國

英國

法國

義大利

俄羅斯

歐洲其他地區

南美洲

巴西

阿根廷

南美洲其他地區

亞太

中國

印度

日本

澳洲

亞太其他地區

中東和非洲

主要進展

2024 年 2 月，凱愛瑞集團推出了 Plenibiotic（乾酪乳桿菌亞種 327），這是一種源自米的後生元，適用於人類和寵物補充劑形式。這種成分得到了科學研究的支持，證明了它對消化和皮膚健康的益處。 Plenibiotics 在各種溫度和環境下都非常穩定，即使在最小劑量下也能確保其保存期限和有效性。

2023 年 10 月，利樂與 AB Biotek 合作推出了一系列創新的後生元食品解決方案。這些後生元以粉末形式提供，可以在超高溫 (UHT) 加工的混合階段有效地摻入。這種整合適用於多種產品，包括飲料、乳製品、冰淇淋和起司。

The postbiotics food supplements market is gaining significant traction due to the scientifically validated health benefits of postbiotics, their high stability profile, and their versatility across various product formats. Postbiotics, the non-viable bacterial products or metabolic byproducts from probiotic microorganisms, are positioned to address a broad spectrum of health issues, including gut health, immunity, and inflammation, driving consumer interest and market growth.

Recent studies indicate that postbiotics can offer more direct immunomodulation effects than probiotics. Specific postbiotic strains have demonstrated a higher increase in IL-12 production in macrophages, which is pivotal for defending against infectious diseases. This leads to beneficial changes in the immune response, enhancing the proliferation of IL-10 and IL-12, and the production of IFN-Y in splenocytes and dendritic cells.

The direct immunomodulation effect of postbiotics provides superior health benefits and mitigates potential negative effects associated with probiotics. This makes postbiotics a safer alternative for immune-compromised populations, such as the elderly or transplant patients.

Furthermore, postbiotics present significant opportunities for product innovation, especially in environments where probiotics are less effective. A key advantage of postbiotics is their stability, which makes them less sensitive to storage conditions and suitable for various delivery formats, including tablets and capsules. This versatility enhances consumer convenience and broadens market potential.

Market Dynamics

Rising Awareness of Postbiotics in Improving Human Health

The increasing awareness and adoption of postbiotics in health and wellness are driving significant growth in the functional foods and dietary supplements sectors. Postbiotics, comprising metabolites and components produced by probiotics, offer a unique value proposition by enhancing human health through various mechanisms without necessitating live microbial consumption. This trend is fueled by rising consumer demand for health-boosting products, a greater focus on gut health, and a growing inclination towards scientifically validated, non-living alternatives to traditional probiotics.

According to an article published in the Scholarly Community Encyclopedia (MDPI) in January 2023, Postbiotics, the bioactive compounds produced during microbial fermentation, have emerged as a promising frontier in health enhancement. These compounds, including lactic acid, bacteriocins, and exopolysaccharides (EPS), exhibit significant antimicrobial properties. For instance, lactic acid and bacteriocins demonstrate direct inhibition of Gram-negative pathogens, highlighting their role in managing pathogenic infections and supporting gut health. Notably, postbiotics derived from Lactobacillus and Bifidobacterium strains have shown efficacy in combating enteroinvasive E. coli and other harmful microorganisms, which can be crucial for maintaining a balanced microbiota and preventing gastrointestinal diseases.

The market potential for postbiotics is bolstered by their stability and safety profiles compared to live probiotics, which often face challenges related to shelf-life and regulatory hurdles. As consumers and healthcare practitioners become more informed about the advantages of postbiotics, including their ability to support gut health and enhance immune function, demand is expected to rise. Companies investing in postbiotics stand to benefit from a growing segment of health-conscious consumers seeking scientifically backed, effective, and safe dietary supplements.

Growing Scientific Evidence Supporting postbiotic Benefits

Scientific research increasingly validates the health benefits of postbiotics, enhancing their appeal in the food supplements market. Postbiotics, the bioactive compounds produced by probiotics during fermentation, are gaining traction due to their stability, safety, and effectiveness in supporting gut health, immune function, and overall well-being. Emerging studies highlight their role in modulating the gut microbiome, reducing inflammation, and improving metabolic health, further solidifying their value proposition. This growing body of evidence supports their incorporation into dietary supplements, positioning postbiotics as a scientifically backed, stable alternative to traditional probiotics and fueling market growth in this segment.

According to the National Library of Medicine, in 2022, necrotizing enterocolitis (NEC) is a critical condition contributing significantly to infant morbidity and mortality. This underscores the urgent need for effective and safe prophylactic treatments. Recent therapeutic studies have identified probiotics as a leading potential intervention for NEC, particularly in preterm infants. However, concerns related to safety and dosage have limited the practical application of probiotics in clinical settings for these vulnerable populations.

Though still under research, postbiotics present a promising alternative or complementary therapy to live probiotics. These are derived from bacterial structures that retain biological activity even after heat-induced destruction of the microorganisms. A recent study in a murine model of immature intestines demonstrated that heat-killed Lactobacillus rhamnosus GG (LGG) exhibits comparable therapeutic efficacy to live probiotics in enhancing intestinal barrier function.

Regulatory Challenges and Compliance Issues

Regulatory challenges and compliance issues pose significant restraints to the postbiotic food supplements market, despite growing awareness of their potential health benefits.

The regulatory landscape for dietary supplements, including postbiotics, varies widely across different regions and countries, creating complexities for manufacturers in terms of product registration, labeling requirements, and health claims substantiation.

Many jurisdictions, including the European Food Safety Authority (EFSA) and the European Pharmacopoeia, have established standards for probiotics and prebiotics, but they have yet to create specific regulations for postbiotics. Similarly, in the United States, the Food and Drug Administration (FDA) has not provided specific guidelines for postbiotics, leaving their regulatory status to be determined based on existing categories applicable to similar products. This regulatory uncertainty can lead to inconsistencies in how postbiotics are marketed and sold across different markets.

Market Segment Analysis

The global postbiotics food supplements market is segmented based on type, form, application, distribution channel, and region.

The Surging Demand For The Use Of Postbiotics In The Food And Beverage Applications

In recent years, postbiotics have emerged as a compelling ingredient within the food and beverage sector, offering substantial potential for innovation and differentiation in product development. Postbiotics, which include bacterial lysates, enzymes, peptides, and metabolites, are gaining traction due to their stability across a range of temperatures and pH levels. This stability allows manufacturers to incorporate postbiotics into various food and beverage products without compromising their functionality, presenting significant technical and financial advantages.

The application of postbiotics in food and beverage products is diverse, encompassing dairy and non-dairy segments. For instance, postbiotics derived from fermentation processes are commonly found in products like kefir, kombucha, yogurt, and pickled vegetables. This natural incorporation of postbiotics enhances the functional profile of these products, catering to the growing consumer demand for functional and health-promoting foods.

The incorporation of postbiotics can also be strategically employed to enhance the sensory and physicochemical attributes of food products. For example, extracellular polysaccharides (EPS) produced by lactic acid bacteria (LAB) can improve the texture and mouthfeel of dairy products, providing a competitive edge in the market. Additionally, postbiotics can facilitate the enrichment of foods with essential vitamins and bioactive compounds. The fermentation process, for instance, can boost levels of B vitamins in cereal grains, compensating for nutrient losses during milling and processing.

Market Geographical Share

Demand for Postbiotics Food Supplements in Asia-Pacific

Asia-Pacific countries such as China, India, and Japan are experiencing rising birth rates and a growing emphasis on maternal and child health. This demographic trend is a significant driver for the demand for nutritional supplements, including postbiotics, which are recognized for their potential to support maternal health during the postnatal period and enhance infant development.

Culturally, countries like China and India place strong emphasis on maternal well-being and the health of newborns. Postbiotics are increasingly sought after due to their perceived benefits in promoting gut health, bolstering immune function, and aligning with traditional healthcare practices that prioritize natural remedies and preventive health measures.

Postbiotics, although a newer segment compared to probiotics and prebiotics, are emerging as a key area of interest. These metabolites produced by probiotic bacteria are gaining recognition for their potential health benefits, including anti-inflammatory and immune-modulating effects. The stability and efficacy of postbiotics are under scrutiny, with ongoing research aimed at validating their health claims and ensuring regulatory compliance.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the postbiotic food supplements market, both positively and negatively. On the positive side, heightened health awareness during the pandemic has led to increased consumer interest in health and wellness products, including postbiotics.

Many consumers have turned to dietary supplements to boost their immune systems, support overall health, and manage stress, leading to a surge in demand for postbiotic products. This trend has been particularly pronounced among new mothers seeking to enhance their postpartum health and well-being, driving growth in the postbiotic food supplements market.

On the negative side, the pandemic has caused significant disruptions to global supply chains, affecting the availability and cost of raw materials necessary for postbiotic supplements. Lockdowns, travel restrictions, and labor shortages have hampered manufacturing and distribution processes, leading to delays and increased costs. Additionally, the economic downturn induced by the pandemic has affected consumer purchasing power, potentially limiting market growth as some consumers may cut back on non-essential spending.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has had significant repercussions on the global supply chain, impacting the postbiotic food supplements market. Both countries are major producers and suppliers of various raw materials and ingredients used in dietary supplements, including postbiotics. The conflict has led to disruptions in the production and export of these critical components, resulting in supply shortages and increased production costs for manufacturers worldwide.

The instability in the region has also caused fluctuations in energy prices, further driving up manufacturing and distribution costs. Consequently, companies in the postbiotic food supplements market have faced challenges in maintaining consistent supply and managing increased costs, which can affect product pricing and availability for consumers.

Moreover, the geopolitical tension has influenced market dynamics by creating uncertainty and affecting consumer confidence. Economic sanctions and trade restrictions imposed on Russia have complicated international trade and business operations, causing delays and uncertainties in market activities. This has particularly impacted European markets, where the dependence on Eastern European raw materials is substantial.

By Type

Short-chain fatty acids

Lipopolysaccharides

Exopolysaccharides

Enzymes

Cell Wall Fragments

Others

By Form

Capsules & Tablets

Liquid

Powder

Others

By Application

Digestive Health

Gut Microbiota/Microbiome Balance

Digestion

Constipation

Bloating

Others

Immune Support

Skin Health

Weight Management

Sports Nutrition

Mental Health

Sleep

Cognition

Mood

Depression

General Wellness

Others

By Distribution Channel

Supermarkets/Hypermarkets

Pharmacies and Drug Stores

Convenience Stores

Online Retailers

Other Distribution Channels

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Russia

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In February 2024, Kerry Group introduced a Plenibiotic (Lactobacillus casei subsp. 327), a rice-derived postbiotic suitable for both human and pet supplement formats. This ingredient is supported by scientific research demonstrating its benefits for digestive and skin health. Plenibiotics are notably stable across various temperatures and environments, ensuring their shelf life and effectiveness even at minimal dosages.

In October 2023, Tetra Pak collaborated with AB Biotek to introduce a range of innovative postbiotic food solutions. These postbiotics, available in powder form, can be efficiently incorporated during the mixing stage of Ultra High Temperature (UHT) processing. This integration is applicable to a variety of products, including beverages, dairy items, ice cream, and cheese.

Competitive Landscape

The major global players in the market include ADM, Cargill, Incorporated., ABbiotek Health, Tetra Pak International S.A., DSM, AB-BIOTICS, SA, Sabinsa, Postbiotica Srl, Lesaffre, and Lactobio A/S.

Why Purchase the Report?

To visualize the global postbiotic food supplements market segmentation based on type, form, application, distribution channel, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of postbiotic food supplements market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global postbiotic food supplements market report would provide approximately 70 tables, 66 figures, and 219 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Awareness of postbiotics on improving human health
  - 4.1.1.2. Growing Scientific Evidence Supporting postbiotic Benefits
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges and Compliance Issues
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Short-chain fatty acids*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Lipopolysaccharides
7.4. Exopolysaccharides
7.5. Enzymes
7.6. Cell Wall Fragments
7.7. Others

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Capsules & Tablets*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Powder
8.4. Liquid
8.5. Others

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Digestive Health*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Gut Microbiota/Microbiome Balance
- 9.2.4. Digestion
- 9.2.5. Constipation
- 9.2.6. Bloating
- 9.2.7. Others
9.3. Immune Support
9.4. Skin Health
9.5. Weight Management
9.6. Sports Nutrition
9.7. Mental Health
- 9.7.1. Sleep
- 9.7.2. Cognition
- 9.7.3. Mood
- 9.7.4. Depression
9.8. General Wellness
9.9. Others

10. By Distribution Channel

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Supermarkets/Hypermarkets*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmacies and Drug Stores
10.4. Convenience Stores
10.5. Online Retailers
10.6. Other Distribution Channels

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. ADM *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Cargill, Incorporated
13.3. ABbiotek Health
13.4. Tetra Pak International S.A.
13.5. DSM
13.6. AB-BIOTICS, SA
13.7. Sabinsa
13.8. Postbiotica Srl
13.9. Lesaffre
13.10. Lactobio A/S (*LIST NOT EXHAUSTIVE)